Plant-Based Therapeutics, Volume 1 Cannabis sativa /

By examining historical applications of the compounds found in plants, this five-volume series serves as a reference for quality assurance, research, product development, and regulatory guidance of the compounds found in plant-based medicines. This work supports the growing consumers' interest...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
1. autor: Ross, Ivan A. (Autor)
Korporacja: SpringerLink (Online service)
Format: Elektroniczne E-book
Język:angielski
Wydane: Cham : Springer International Publishing : Imprint: Springer, 2023.
Wydanie:1st ed. 2023.
Hasła przedmiotowe:
Dostęp online:https://doi.org/10.1007/978-3-031-35155-6
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

MARC

LEADER 00000nam a22000005i 4500
001 978-3-031-35155-6
003 DE-He213
005 20260810160313.0
007 cr nn 008mamaa
008 230808s2023 sz | o |||| 0|eng d
020 |a 9783031351556  |9 978-3-031-35155-6 
024 7 |a 10.1007/978-3-031-35155-6  |2 doi 
050 4 |a QK 
072 7 |a PST  |2 bicssc 
072 7 |a SCI011000  |2 bisacsh 
072 7 |a PST  |2 thema 
082 0 4 |a 580  |2 23 
100 1 |a Ross, Ivan A.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 0 |a Plant-Based Therapeutics, Volume 1  |h [electronic resource] :  |b Cannabis sativa /  |c by Ivan A. Ross. 
250 |a 1st ed. 2023. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2023. 
300 |a 1 online resource (XXI, 657 p.). 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
341 0 |b Table of contents navigation  |2 onix 
341 0 |b Single logical reading order  |2 onix 
341 0 |b Use of color is not sole means of conveying information  |2 onix 
341 0 |b Use of high contrast between text and background color  |2 onix 
341 0 |b Next / Previous structural navigation  |2 onix 
341 0 |b All non-decorative content supports reading without sight  |2 onix 
347 |a text file  |b PDF  |2 rda 
505 0 |a Chapter 1 The History of Cannabis -- Chapter 2 The Bioactive Components of Plants -- Chapter 3 Chemical Constituents of Cannabis -- Chapter 4 The Bioactive Components of Cannabis -- Chapter 5 Neurological Effects of Cannabis -- Chapter 6 Psychotropic Effects of Cannabis -- Chapter 7 The Analgesic effects of Cannabis -- Chapter 8 Cannabis and Perinatal Development -- Chapter 9 Cannabis and Multiple Sclerosis -- Chapter 10 Cannabis and Cancer -- Chapter 11 Cannabis and Parkinson’s disease -- Chapter 12 Cannabis and the Skin -- Chapter 13 Antiviral Activities of Cannabis -- Chapter 14 Alkaline Phosphatase Stimulation. 
520 |a By examining historical applications of the compounds found in plants, this five-volume series serves as a reference for quality assurance, research, product development, and regulatory guidance of the compounds found in plant-based medicines. This work supports the growing consumers' interest in herbal medicine for wellness and health. Plant-Based Therapeutics, Volume 1: Cannabis sativa, the first in the series, covers a unique plant species and provides the framework to integrate its evidence-based scientific discoveries with healthcare therapies. Cannabis has been used in religious ceremonies and medical purposes for thousands of years. Cannabidiol (CBD), the main non-psychoactive component of Cannabis, was isolated in the 1940s, and its structure was established in the 1960s. In 1964 tetrahydrocannabinol (THC), the psychoactive component, was isolated. Cannabis has more than 500 components, of which 104 cannabinoids have been identified. Two of them, THC and CBD, have been the primary components of scientific investigations. They were approved by the FDA for chemotherapy-induced nausea and vomiting in 1985; for appetite stimulation in wasting conditions, such as AIDS, in 1992, and in 2018 for treating two forms of pediatric epilepsy, Dravet syndrome and Lennox-Gastaut syndrome. Beyond the indications for which cannabinoids are FDA-approved, the evidence reveals that cannabinoid receptors are present throughout the body, embedded in cell membranes, and are believed to be more numerous than any other receptor system. When cannabinoid receptors are stimulated, a variety of physiologic processes ensue. Thus, other constituents of Cannabis are extremely promising either as individual compounds or their potential synergistic or entourage effects in the treatment of numerous medical conditions. . 
532 8 |a Accessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. 
532 8 |a No reading system accessibility options actively disabled 
532 8 |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com 
588 |a Print version record. 
650 0 |a Botany. 
650 0 |a Alternative medicine. 
650 0 |a Pharmacology. 
650 0 |a Medicinal chemistry. 
650 0 |a Physiology. 
650 0 |a Agriculture. 
650 1 4 |a Plant Science. 
650 2 4 |a Complementary and Alternative Medicine. 
650 2 4 |a Pharmacology. 
650 2 4 |a Medicinal Chemistry. 
650 2 4 |a Physiology. 
650 2 4 |a Agriculture. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783031351549 
776 0 8 |i Printed edition:  |z 9783031351563 
776 0 8 |i Printed edition:  |z 9783031351570 
856 4 0 |u https://doi.org/10.1007/978-3-031-35155-6 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)